Medicare Enrolled
Dr. Luis Chu, M.D.
Medical Oncology · Sarasota, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chu? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Chu
Dr. Luis Chu is a medical oncology in Sarasota, FL, with 20 years in practice. Based on federal Medicare data, Dr. Chu performed 208,084 Medicare services across 5,212 unique beneficiaries.
Between the years covered by Open Payments, Dr. Chu received a total of $12,008 from 77 pharmaceutical and/or device companies across 784 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chu is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 12% volume in FL$ $12,008 industry payments
Medicare Practice Summary
Medicare Utilization ↗208,084
Medicare services
Top 12% in FL for medical oncology
5,212
Unique beneficiaries
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~10,404 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 43,860 | $0 | $4 |
| Daratumumab injection (Darzalex) | 30,780 | $38 | $110 |
| Filgrastim injection (Zarxio) for white blood cells | 30,360 | $0 | $2 |
| Anti-nausea injection (aprepitant) | 15,990 | $1 | $5 |
| Pembrolizumab injection (Keytruda) | 13,000 | $43 | $137 |
| Denosumab injection (Prolia/Xgeva) | 12,780 | $18 | $51 |
| Epoetin alfa injection (Procrit) for anemia | 10,620 | $6 | $23 |
| Immune globulin infusion (Gammagard) | 10,464 | $36 | $108 |
| Paclitaxel chemotherapy injection | 7,181 | $0 | $2 |
| Injection, eflapegrastim-xnst, 0.1 mg | 6,072 | $26 | $116 |
| Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 4,703 | $23 | $183 |
| Complete blood count (CBC) with differential | 3,753 | $8 | $29 |
| Blood draw (venipuncture) | 3,519 | $8 | $9 |
| Dexamethasone injection (steroid) | 2,550 | $0 | $3 |
| Office visit, established patient (30-39 min) | 2,074 | $94 | $339 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,830 | $1 | $28 |
| Drug injection, under skin or into muscle | 864 | $10 | $69 |
| Injection of additional new drug or substance into vein | 851 | $12 | $61 |
| Cyclophosphamide, 100 mg | 681 | $15 | $79 |
| Administration of chemotherapy into vein, 1 hour or less | 580 | $97 | $378 |
| Anti-nausea injection (ondansetron/Zofran) | 548 | $0 | $9 |
| Injection, doxorubicin hydrochloride, 10 mg | 488 | $2 | $13 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 376 | $46 | $189 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 371 | $53 | $206 |
| Injection, diphenhydramine hcl, up to 50 mg | 324 | $1 | $3 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 318 | $15 | $56 |
| Administration of chemotherapy into vein, each additional hour | 286 | $21 | $79 |
| Injection, zoledronic acid, 1 mg | 276 | $7 | $69 |
| Office visit, established patient (20-29 min) | 262 | $64 | $239 |
| Red blood count automated, with additional calculations | 201 | $5 | $20 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 189 | $21 | $84 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 186 | $17 | $59 |
| Office visit, established patient, complex (40-54 min) | 174 | $137 | $474 |
| Administration of additional new drug or substance into vein, 1 hour or less | 159 | $49 | $178 |
| Infusion into a vein for hydration, each additional hour | 138 | $10 | $42 |
| Injection, carboplatin, 50 mg | 138 | $2 | $41 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 126 | $137 | $562 |
| New patient office visit (45-59 min) | 117 | $122 | $453 |
| Administration of additional new drug or substance into vein using push technique | 113 | $42 | $170 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 111 | $1 | $6 |
| Injection of drug or substance into vein | 107 | $28 | $156 |
| Infusion, normal saline solution , 1000 cc | 101 | $2 | $7 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 95 | $3 | $11 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 81 | $25 | $89 |
| Infusion into a vein for hydration, 31-60 minutes | 79 | $24 | $156 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 63 | $1 | $7 |
| Automated urinalysis | 36 | $2 | $8 |
| Drawing of blood for a medical problem | 36 | $69 | $277 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 32 | $131 | $467 |
| New patient office visit, complex (60-74 min) | 30 | $167 | $585 |
| New patient office visit (30-44 min) | 11 | $82 | $298 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
26.7% high complexity
67.8% medium
5.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$12,008
Total received (2018-2024)
Avg $2,001/year across 6 years
Top 40% in FL for medical oncology
77
Companies
784
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,815 (98.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$193 (1.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$3,011
2023$3,396
2022$916
2020$230
2019$2,109
2018$2,346
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$994
E.R. Squibb & Sons, L.L.C.
$782
Genentech USA, Inc.
$743
PFIZER INC.
$674
Janssen Biotech, Inc.
$646
Merck Sharp & Dohme LLC
$599
Celgene Corporation
$552
Merck Sharp & Dohme Corporation
$511
Lilly USA, LLC
$407
Gilead Sciences, Inc.
$366
Takeda Pharmaceuticals U.S.A., Inc.
$361
Incyte Corporation
$305
GENZYME CORPORATION
$293
Daiichi Sankyo Inc.
$290
GlaxoSmithKline, LLC.
$289
Amgen Inc.
$253
BeiGene USA, Inc.
$244
Astellas Pharma US Inc
$241
Pharmacyclics LLC, An AbbVie Company
$234
Adaptive Biotechnologies Corporation
$233
Exelixis Inc.
$213
Seagen Inc.
$209
ABBVIE INC.
$184
AstraZeneca Pharmaceuticals LP
$169
Regeneron Healthcare Solutions, Inc.
$164
Rigel Pharmaceuticals, Inc.
$128
ARRAY BIOPHARMA INC
$111
JAZZ PHARMACEUTICALS INC.
$95
Mirati Therapeutics, Inc.
$87
TAIHO ONCOLOGY, INC.
$84
Dendreon Pharmaceuticals LLC
$81
Genentech, Inc.
$80
Ipsen Biopharmaceuticals, Inc
$77
G1 Therapeutics, Inc.
$76
Puma Biotechnology, Inc.
$75
AbbVie, Inc.
$73
Kite Pharma, Inc.
$64
PharmaEssentia USA Corporation
$62
Eisai Inc.
$61
RECORDATI_RARE_DISEASES_INC.
$58
TerSera Therapeutics LLC
$53
AbbVie Inc.
$47
Alexion Pharmaceuticals, Inc.
$47
Bayer HealthCare Pharmaceuticals Inc.
$45
Aveo Pharmaceuticals, Inc.
$36
MorphoSys, US Inc.
$36
Sysmex Inostics Inc
$33
Array BioPharma Inc.
$31
EMD Serono, Inc.
$30
Helsinn Therapeutics (U.S.), Inc.
$30
Sumitomo Pharma America, Inc.
$29
ADC Therapeutics America, Inc.
$27
Spectrum Pharmaceuticals Inc.
$24
NanoString Technologies, Inc.
$24
Pharmacyclics LLC, an AbbVie Company
$23
INSYS Therapeutics Inc
$23
SERVIER PHARMACEUTICALS LLC
$22
EUSA Pharma (US) LLC
$20
CTI BioPharma Corp.
$18
Deciphera Pharmaceuticals Inc.
$18
Boehringer Ingelheim Pharmaceuticals, Inc.
$17
SOBI, INC
$17
AVEO Pharmaceuticals, Inc.
$17
Blueprint Medicines Corporation
$17
Karyopharm Therapeutics Inc.
$16
Shire North American Group Inc
$16
Taiho Oncology, Inc.
$15
Janssen Pharmaceuticals, Inc
$15
PUMA BIOTECHNOLOGY, INC.
$14
Apellis Pharmaceuticals, Inc.
$13
Agios Pharmaceuticals, Inc.
$13
MENARINI SILICON BIOSYSTEMS, INC.
$12
Jazz Pharmaceuticals Inc.
$12
Medtronic USA, Inc.
$11
Heron Therapeutics, Inc.
$11
Fortovia Therapeutics, Inc.
$5
Veracyte, Inc.
$0
Top 3 companies account for 21.0% of total payments
Associated products mentioned in payments ›
6 · ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CERDELGA · CEREZYME · COSELA · CYRAMZA · Cabometyx · Cellsearch · Columvi · DARZALEX · Doptelet · ELAHERE · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · Empaveli · Enhertu · Erleada · FOTIVDA · FRUZAQLA · Fabhalta · GAUCHER-DISEASE · GAZYVA · GILOTRIF · HYQVIA · IBRANCE · IMBRUVICA · IMFINZI · INFLECTRA · INLYTA · Imbruvica · JADENU · JAKAFI · JAYPIRCA · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LENVIMA · LIBTAYO · LONSURF · LORBRENA · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · PADCEV · PANHEMATIN · PLUVICTO · PROMACTA · PROSIGNA ASSAY · PROVENGE · Padcev · Perjeta · Pomalyst · Prolia · QINLOCK · Quzyttir · REBLOZYL · ROLVEDON · RYBREVANT · RYDAPT · Rezlidhia · Rituxan Hycela · SANDOSTATIN · SARCLISA · SCEMBLIX · SHINGRIX · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · SYLVANT · SYNCHROMED · SYNDROS · Sylvant · TABRECTA · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VONVENDI · VOTRIENT · VYXEOS · Venclexta · Vonjo · XALKORI · XOSPATA · XPOVIO · XTANDI · Yescarta · ZEPZELCA · ZOLADEX · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $6 per 100 Medicare services performed
Geographic Context
Medical Oncologys within 10 mi
12
Per 100K population
2.7
County median income
$80,633
Nearest hospital
SARASOTA MEMORIAL HOSPITAL
2.6 mi
2.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Chu is a mixed practice specialist, with above-average Medicare volume (top 12% in FL), and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Chu experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Chu performed 43,860 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chu receive payments from pharmaceutical companies?
Yes. Dr. Chu received a total of $12,008 from 77 companies across 784 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chu's costs compare to other medical oncologys in Sarasota?
Dr. Chu's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologys in Sarasota
Browse medical oncologys in Sarasota ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologys in FL
Medical Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologys in FL
Which FL medical oncologys receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C..
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology